U.S. Markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.3402%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.81
    +2.12 (+11.34%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.4286%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.1613%)
     
  • BTC-USD

    48,093.82
    +900.14 (+1.91%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

New Strong Sell Stocks for September 4th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Amyris, Inc. AMRS is a biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 61.8% downward over the last 30 days.

Hess Midstream LP HESM owns, operates, develops, and acquires midstream assets. The Zacks Consensus Estimate for its current year earnings has been revised 30% downward over the last 30 days.

Itamar Medical Ltd. ITMR engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The Zacks Consensus Estimate for its current year earnings has been revised 18.4% downward over the last 30 days.

eMagin Corporation EMAN designs, develops, manufactures, and markets organic light emitting diode displays. The Zacks Consensus Estimate for its current year earnings has been revised 85.7% downward over the last 30 days.

Altisource Portfolio Solutions S.A. ASPS operates as an integrated service provider and marketplace for the real estate and mortgage industries. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Amyris, Inc. (AMRS) : Free Stock Analysis Report
 
eMagin Corporation (EMAN) : Free Stock Analysis Report
 
Altisource Portfolio Solutions S.A. (ASPS) : Free Stock Analysis Report
 
Hess Midstream Partners LP (HESM) : Free Stock Analysis Report
 
Itamar Medical Ltd. Sponsored ADR (ITMR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research